Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · IEX Real-Time Price · USD
0.650
+0.018 (2.85%)
At close: Apr 23, 2024, 4:00 PM
0.669
+0.019 (2.92%)
After-hours: Apr 23, 2024, 7:31 PM EDT
Monopar Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MNPR stock have an average target of 9.50, with a low estimate of 2.00 and a high estimate of 17. The average target predicts an increase of 1,361.54% from the current stock price of 0.65.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MNPR stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Hold → Strong Buy Upgrades $2 | Hold → Strong Buy | Upgrades | $2 | +207.69% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +2,515.38% | Jun 1, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $2 | Strong Buy | Maintains | $6 → $2 | +207.69% | May 15, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 29, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $24 → $17 | Strong Buy | Maintains | $24 → $17 | +2,515.38% | Mar 28, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.60
from -0.61
EPS Next Year
-0.57
from -0.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 4.5M | 44.9M |
| Avg | n/a | n/a | n/a | 2.2M | 30.5M |
| Low | n/a | n/a | n/a | n/a | 16.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,951.9% |
| Avg | - | - | - | - | 1,293.7% |
| Low | - | - | - | - | 663.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.61 | -0.53 | -0.37 | -0.55 | - |
| Avg | -0.60 | -0.57 | -0.55 | -0.53 | - |
| Low | -0.58 | -0.61 | -0.71 | -0.51 | - |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.